Therapy of pseudomonal infections.
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002228:Carbenicillin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D010093:Oxolinic Acid / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000628:therapy*; D013845:Thienamycins / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D013845:Thienamycins; D002228:Carbenicillin; D010093:Oxolinic Acid